Showing results (281-290 of 296) with videos related to
Sort By:
Pageof 30
Leukemia|June 24, 2017
Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myelomaA Laganà, D Perumal, D Melnekoff, et al.Leukemia|March 11, 2015
The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myelomaX Papanikolaou, D Alapat, A Rosenthal, et al.Blood|December 24, 1998
Total therapy with tandem transplants for newly diagnosed multiple myelomaB Barlogie, S Jagannath, K R Desikan, et al.Leukemia|October 4, 2012
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative projectH Avet-Loiseau, B G M Durie, M Cavo, et al.Blood Cancer Journal|July 30, 2016
Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myelomaY Jethava, A Mitchell, M Zangari, et al.Leukemia|December 17, 2015
Genetic factors influencing the risk of multiple myeloma bone diseaseD C Johnson, N Weinhold, J Mitchell, et al.Leukemia|December 22, 2018
Combination of flow cytometry and functional imaging for monitoring of residual disease in myelomaL Rasche, D Alapat, M Kumar, et al.Leukemia|October 3, 2009
International Myeloma Working Group molecular classification of multiple myeloma: spotlight reviewR Fonseca, P L Bergsagel, J Drach, et al.Nature Communications|August 18, 2017
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencingL Rasche, S S Chavan, O W Stephens, et al.Leukemia|April 23, 2010
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and managementR A Kyle, B G M Durie, S V Rajkumar, et al.Pageof 30